Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Sumatriptan succinate

Related Products

Hot Products

Name

Sumatriptan succinate

EINECS 600-463-4
CAS No. 103628-48-4 Density 1.243 g/cm3
PSA 148.18000 LogP 2.72870
Solubility N/A Melting Point 165-166°C
Formula C18H27N3O6S Boiling Point 497.7 °C at 760 mmHg
Molecular Weight 413.495 Flash Point 254.8 °C
Transport Information N/A Appearance white powder
Safety 26-36 Risk Codes 36/37/38
Molecular Structure Molecular Structure of 103628-48-4 (Sumatriptan succinate) Hazard Symbols IrritantXi
Synonyms

Sumatriptan Alginate;1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide succinate;3-(2-(Dimethylamino)ethyl)-N-methylindole-5-methanesulfonamide succinate (1:1);Antibet;Arcoiran;Diletan;GR 43175C;Imigran;

Article Data 7

Sumatriptan succinate Synthetic route

103628-46-2

sumatripan

103628-48-4

sumatriptan succinate

Conditions
ConditionsYield
With succinic acid In acetone at 25 - 35℃; for 1 - 2h; Heating / reflux;
With succinic acid In dichloromethane at 25 - 35℃; for 1 - 1.5h; Heating / reflux;
With succinic acid In ethyl acetate at 25 - 35℃; for 1 - 2h; Heating / reflux;
110-15-6

succinic acid

103628-46-2

sumatripan

103628-48-4

sumatriptan succinate

Conditions
ConditionsYield
Stage #1: succinic acid; sumatripan In water; acetonitrile for 0.25 - 0.5h; Heating / reflux;
Stage #2: In cyclohexane at 25 - 35℃; for 1 - 2h;
In acetone for 2h; Purification / work up; Heating / reflux;
In dichloromethane for 4h; Purification / work up; Heating / reflux;
103628-48-4

sumatriptan succinate

103628-46-2

sumatripan

Conditions
ConditionsYield
With sodium hydrogencarbonate In water

Sumatriptan succinate Specification

The Sumatriptan succinate with CAS registry number of 103628-48-4 is also known as 1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide succinate. The IUPAC name is Butanedioic acid; 1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide. It belongs to product categories of Indoles and derivatives; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; Sumatriptan; Serotonin receptor. In addition, the formula is C18H27N3O6S and the molecular weight is 413.49. This chemical is a white crystalline powder and it is used as a serotonin 5HT1-receptor agonist.

Physical properties about Sumatriptan succinate are: (1)ACD/LogP: 0.67; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -2.35; (4)ACD/LogD (pH 7.4): -1.21; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 5; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 5; (12)Flash Point: 254.8 °C; (13)Enthalpy of Vaporization: 76.57 kJ/mol; (14)Boiling Point: 497.7 °C at 760 mmHg; (15)Vapour Pressure: 4.83E-10 mmHg at 25 °C.

Preparation of Sumatriptan succinate: it is prepared by reaction of 4-hydrazino-N-methyl, benzyl sulfonamide hydrochloride and 4,4-dimethoxy-N, N-dimethyl-butylamine. The reaction needs catalysts polyphosphoric acid and sodium dihydrogen phosphate. Isopropyl ether and acetone are used as the recrystallization solvents. At last, product is obtained by condensation, rearrangement, cyclization. The yield is about 12.7%.

When you are using this chemical, please be cautious about it. As a chemical, it is irritating to eyes, respiratory system and skin. During using it, wear suitable protective clothing. If contact with eyes accidently, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
1. Canonical SMILES: CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O
2. InChI: InChI=1S/C14H21N3O2S.C4H6O4/c1-15-20(18,
19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3;5-3(6)1-2-4(7)8/h4-5,8-9,
15-16H,6-7,10H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
3. InChIKey: PORMUFZNYQJOEI-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD oral > 700mg/kg (700mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ATAXIA

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2065, 1993.
dog LD subcutaneous > 140mg/kg (140mg/kg) BEHAVIORAL: TREMOR

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2065, 1993.
rat LD50 intravenous 43112ug/kg (43.112mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

LIVER: OTHER CHANGES
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2059, 1993.
rat LD50 oral > 2939mg/kg (2939mg/kg) BEHAVIORAL: TREMOR

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2059, 1993.
rat LD50 subcutaneous 1680mg/kg (1680mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: CYANOSIS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 2059, 1993.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103628-48-4